Who are Lavasept 0.04%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): .02% Chlorohexidine Gluconate, Adapalene/benzoyl peroxide gel, 0.1%/2.5%, adapalene/benzoyl peroxide, Chlorhexidine oral care, Adapalene + benzoyl peroxide samples, Chlorhexidine 0.06% mouthrinse.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lavasept-0-04.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Lavasept 0.04% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lavasept 0.04% (Lavasept 0.04%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial antiseptic. Area: Infection Control / Dermatology.

marketed Antimicrobial antiseptic Bacterial cell membrane and proteins Infection Control / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Lavasept 0.04% (Lavasept 0.04%) — B. Braun Ltd. Centre of Excellence Infection Control. Lavasept is an antimicrobial skin antiseptic that kills bacteria and other microorganisms through oxidative damage.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Lavasept 0.04% TARGET	Lavasept 0.04%	B. Braun Ltd. Centre of Excellence Infection Control	marketed	Antimicrobial antiseptic	Bacterial cell membrane and proteins
.02% Chlorohexidine Gluconate	.02% Chlorohexidine Gluconate	Riyadh Colleges of Dentistry and Pharmacy	marketed	Antimicrobial/Antiseptic agent	Bacterial cell membrane and proteins
Adapalene/benzoyl peroxide gel, 0.1%/2.5%	Adapalene/benzoyl peroxide gel, 0.1%/2.5%	Galderma R&D	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
adapalene/benzoyl peroxide	adapalene/benzoyl peroxide	Galderma R&D	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Chlorhexidine oral care	Chlorhexidine oral care	University of Pavia	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Adapalene + benzoyl peroxide samples	Adapalene + benzoyl peroxide samples	Wake Forest University	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Chlorhexidine 0.06% mouthrinse	Chlorhexidine 0.06% mouthrinse	University of Oslo	marketed	Antimicrobial oral rinse	Bacterial cell membrane and proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial antiseptic class)

B. Braun Ltd. Centre of Excellence Infection Control · 1 drug in this class
Baycrest · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lavasept 0.04% — Competitive Intelligence Brief. https://druglandscape.com/ci/lavasept-0-04. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing